Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncol Nurs Forum. 2009 Nov;36(6):676-85. doi: 10.1188/09.ONF.676-685.

Trastuzumab-induced cardiotoxicity.

Author information

1
Duke Health Systems, Duke Oncology Network, Durham, NC, USA. lisa.moss@duke.edu

Abstract

PURPOSE/OBJECTIVES:

To review trastuzumab-related cardiotoxic effects in the breast cancer adjuvant setting, present a system for pretreatment screening for cardiovascular risk factors, describe monitoring recommendations, provide a tool to facilitate adherence to monitoring guidelines, and discuss implications for patient education.

DATA SOURCES:

Literature regarding cardiotoxicity and trastuzumab in breast cancer.

DATA SYNTHESIS:

Trastuzumab was approved in 2006 for use in the adjuvant setting. A small percentage of women (approximately 4%) developed heart failure during or after treatment. However, the trials excluded women with cardiac disease. Current screening for cardiotoxicity relies on sequential left ventricular function measurements with either echocardiography or multigated acquisition scanning at baseline and every three months. Treatment modifications are recommended if changes from baseline are detected. Long-term and late effects have yet to be determined.

CONCLUSIONS:

Although a small number of women experienced cardiotoxicity in the adjuvant setting, an increase may be seen because women with preexisting heart disease receive this treatment. Guidelines and tools will be helpful for appropriate and consistent screening of cardiac risk factors and disease prior to initiation of trastuzumab and for monitoring during and after administration.

IMPLICATIONS FOR NURSING:

Nurses are instrumental in assessing, monitoring, and treating women receiving trastuzumab. Implementing guidelines to promote adherence to recommended monitoring is important in the early detection of cardiotoxicity in this population. Educating women about their treatment and side effects is an important aspect of care.

PMID:
19887355
DOI:
10.1188/09.ONF.676-685
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Oncology Nursing Society
    Loading ...
    Support Center